---
title: "EASTON BIOPHARMACEUTICALS: Pirfenidone tablets have obtained a drug registration certificate"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/256086478.md"
description: "According to the Zhitong Finance APP, EASTON BIOPHARMACEUTICALS announced that the company recently received the drug registration certificate for Pirfenidone Tablets approved and issued by the National Medical Products Administration (referred to as \"NMPA\"). The main active ingredient of Pirfenidone Tablets is Pirfenidone, which is classified as a Class II controlled substance under the National Regulations on the Administration of Narcotic Drugs and Psychotropic Substances. It is indicated for the treatment of partial seizures in adults and children aged 4 years and older (with or without secondary generalized seizures)"
datetime: "2025-09-05T08:37:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/256086478.md)
  - [en](https://longbridge.com/en/news/256086478.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/256086478.md)
generator: "portal-rs"
---

# EASTON BIOPHARMACEUTICALS: Pirfenidone tablets have obtained a drug registration certificate

According to the Zhitong Finance APP, EASTON BIOPHARMACEUTICALS (688513.SH) announced that it recently received the drug registration certificate for Pirfenidone Tablets issued by the National Medical Products Administration (referred to as "NMPA").

The main active ingredient of Pirfenidone Tablets is Pirfenidone, which is classified as a Class II psychotropic drug according to the National Regulations on the Administration of Narcotic Drugs and Psychotropic Substances. It is indicated for the treatment of partial seizures in adults and children aged 4 years and older (with or without secondary generalized seizures)

### Related Stocks

- [688513.CN](https://longbridge.com/en/quote/688513.CN.md)

## Related News & Research

- [Pandora board member Lars Sandahl Sørensen buys shares for DKK 164,308](https://longbridge.com/en/news/296865688.md)
- [Promise Analyzes Telehealth Licensing Rules as Compact Hits Record 3,633 Licenses in a Month](https://longbridge.com/en/news/296635882.md)
- [BMS Holdings Q4 FY2026 PAT Rises 106.5% QoQ to RM5.04 Million](https://longbridge.com/en/news/296892849.md)
- [Dino Polska S.A. (WSE:DNP) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year](https://longbridge.com/en/news/296763667.md)
- [08:36 ETUltimate Men's HQ Launches Private Product-Match Education Experience](https://longbridge.com/en/news/296789283.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**